The Department of Defense offers the Neurofibromatosis Investigator-Initiated Research Award to support basic and clinically oriented research focused on enhancing the understanding, diagnosis, and treatment of Neurofibromatosis and related diseases. The grant encourages proposals addressing critical needs of the NF community such as complications with high mortality and morbidity, refinement of imaging techniques, and translational research for therapeutic development. Collaborative research between basic and clinical scientists is highly encouraged. Clinical trials are not eligible under this mechanism. Applications should include relevant preliminary data and may involve collaborations with industry scientists for a higher level of funding. Closing date is April 14, 2009.
Opportunity ID: 44812
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-NFRP-IIRA |
| Funding Opportunity Title: | DOD Neurofibromatosis Investigator-Initiated Research Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 20, 2009 |
| Last Updated Date: | Jan 20, 2009 |
| Original Closing Date for Applications: | Apr 14, 2009 |
| Current Closing Date for Applications: | Apr 14, 2009 |
| Archive Date: | May 14, 2009 |
| Estimated Total Program Funding: | $4,600,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The NFRP Investigator-Initiated Research Award (IIRA) mechanism was first offered in FY96. Since that time, 293 IIRA applications have been received, and 86 have been recommended for funding. The NFRP IIRA supports basic and clinically oriented research that will: Provide insight into the development of NF and related diseases, Result in substantial improvements over todays approach to the diagnosis and treatment of NF and Schwannomatosis, and Enhance the quality of life of persons with those diseases.DOD Neurofibromatosis Investigator-Initiated Research Award3Areas of Encouragement (Revised for FY09): The FY09 NFRP encourages research proposals that specifically address the critical needs of the NF community in the following areas: Complications of NF with high mortality such as neoplasms and cerebrovascular abnormalities; Complications of NF with high morbidity such as skeletal maladies, learning deficits, hormone-associated effects, and pain; Refinement and standardization of imaging techniques, molecular and cellular markers, and quality of life metrics for use in future clinical trials; and Translational research such as the development or preclinical testing of therapeutic agents for the treatment of NF.Clinical trials are not allowed under this mechanism. Principal Investigators (PIs) wishing to apply for funding for a clinical trial should utilize the Clinical Trial Award mechanism. Applications must include preliminary data originating from the PI, research team, or collaborator that is relevant to NF and the proposed project.Optional Qualified Collaborator(s): The FY09 NFRP strongly supports collaborative research between basic scientists and clinical researchers, and between academic scientists and biotechnology/pharmaceutical industry scientists. Collaborations that bring new perspectives from other disciplines or bring new investigators into the NF field are also strongly encouraged. Collaborations that meet the criteria below will qualify for a higher level of funding as described in Section I.D. See the Program Announcement for the full Funding Opportunity Description. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| This modification corrects the Estimated Total Program Funding to $4,600,000.00. | Jan 20, 2009 | |
| Jan 20, 2009 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-NFRP-IIRA |
| Funding Opportunity Title: | DOD Neurofibromatosis Investigator-Initiated Research Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 20, 2009 |
| Last Updated Date: | Jan 20, 2009 |
| Original Closing Date for Applications: | Apr 14, 2009 |
| Current Closing Date for Applications: | Apr 14, 2009 |
| Archive Date: | May 14, 2009 |
| Estimated Total Program Funding: | $4,600,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The NFRP Investigator-Initiated Research Award (IIRA) mechanism was first offered in FY96. Since that time, 293 IIRA applications have been received, and 86 have been recommended for funding. The NFRP IIRA supports basic and clinically oriented research that will: Provide insight into the development of NF and related diseases, Result in substantial improvements over todays approach to the diagnosis and treatment of NF and Schwannomatosis, and Enhance the quality of life of persons with those diseases.DOD Neurofibromatosis Investigator-Initiated Research Award3Areas of Encouragement (Revised for FY09): The FY09 NFRP encourages research proposals that specifically address the critical needs of the NF community in the following areas: Complications of NF with high mortality such as neoplasms and cerebrovascular abnormalities; Complications of NF with high morbidity such as skeletal maladies, learning deficits, hormone-associated effects, and pain; Refinement and standardization of imaging techniques, molecular and cellular markers, and quality of life metrics for use in future clinical trials; and Translational research such as the development or preclinical testing of therapeutic agents for the treatment of NF.Clinical trials are not allowed under this mechanism. Principal Investigators (PIs) wishing to apply for funding for a clinical trial should utilize the Clinical Trial Award mechanism. Applications must include preliminary data originating from the PI, research team, or collaborator that is relevant to NF and the proposed project.Optional Qualified Collaborator(s): The FY09 NFRP strongly supports collaborative research between basic scientists and clinical researchers, and between academic scientists and biotechnology/pharmaceutical industry scientists. Collaborations that bring new perspectives from other disciplines or bring new investigators into the NF field are also strongly encouraged. Collaborations that meet the criteria below will qualify for a higher level of funding as described in Section I.D. See the Program Announcement for the full Funding Opportunity Description. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-NFRP-IIRA |
| Funding Opportunity Title: | DOD Neurofibromatosis Investigator-Initiated Research Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 20, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Apr 14, 2009 |
| Archive Date: | May 14, 2009 |
| Estimated Total Program Funding: | $4,600,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The NFRP Investigator-Initiated Research Award (IIRA) mechanism was first offered in FY96. Since that time, 293 IIRA applications have been received, and 86 have been recommended for funding. The NFRP IIRA supports basic and clinically oriented research that will: Provide insight into the development of NF and related diseases, Result in substantial improvements over todays approach to the diagnosis and treatment of NF and Schwannomatosis, and Enhance the quality of life of persons with those diseases. DOD Neurofibromatosis Investigator-Initiated Research Award 3 Areas of Encouragement (Revised for FY09): The FY09 NFRP encourages research proposals that specifically address the critical needs of the NF community in the following areas: Complications of NF with high mortality such as neoplasms and cerebrovascular abnormalities; Complications of NF with high morbidity such as skeletal maladies, learning deficits, hormone-associated effects, and pain; Refinement and standardization of imaging techniques, molecular and cellular markers, and quality of life metrics for use in future clinical trials; and Translational research such as the development or preclinical testing of therapeutic agents for the treatment of NF. Clinical trials are not allowed under this mechanism. Principal Investigators (PIs) wishing to apply for funding for a clinical trial should utilize the Clinical Trial Award mechanism. Applications must include preliminary data originating from the PI, research team, or collaborator that is relevant to NF and the proposed project. Optional Qualified Collaborator(s): The FY09 NFRP strongly supports collaborative research between basic scientists and clinical researchers, and between academic scientists and biotechnology/pharmaceutical industry scientists. Collaborations that bring new perspectives from other disciplines or bring new investigators into the NF field are also strongly encouraged. Collaborations that meet the criteria below will qualify for a higher level of funding as described in Section I.D. See the Program Announcement for the full Funding Opportunity Description. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Related Documents
Folder 44812 Full Announcement-1 -> NF09 IIRA_PA FINAL 20 JAN 09.pdf
Folder 44812 Full Announcement-1 -> biosketch.pdf
Folder 44812 Full Announcement-1 -> Budget Form Reader.pdf
Packages
| Agency Contact Information: | PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org Email: cdmrp.pa@amedd.army.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00010070 | Jan 20, 2009 | Apr 14, 2009 | View |
Package 1
Mandatory forms
44812 RR_SF424-1.1.pdf
44812 RR_PerformanceSite-1.1.pdf
44812 RR_KeyPersonExpanded-1.1.pdf
Leave a Reply